Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mechnikov probiotics
- Development stage
- Unknown
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
**Mechnikov probiotics** is an orally administered probiotic product evaluated as a perioperative adjunct in patients undergoing anterior resection for sigmoid colon cancer. In the registered double-blind, randomized, placebo-controlled study NCT03531606, participants received one packet twice daily for four weeks, beginning one week before surgery and continuing for three weeks after surgery; the stated objectives included assessment of postoperative anterior resection syndrome symptoms, bowel function, quality of life, inflammatory markers, nutritional status, complications, gut microbiota, and short-chain fatty acids. The public trial record does not identify the constituent microbial strains, viable counts, manufacturer, or a defined molecular target; therefore it cannot be resolved to a specific INN or strain-level live biotherapeutic product. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03531606))
- Brand names
- Mechnikov probiotics
- Other names
- Mechnicov probioticsMetchnik probiotic
Beyond the preview
Go deeper on Mechnikov probiotics.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mechnikov probiotics.